FDA Clearance Tracker · P020056
NATRELLE SILICONE-FILLED BREAST IMPLANTS
Last checked: Nov 20, 2026Latest source record: Nov 17, 2006 (this decision)Source: openFDAMethods & limitations
Decided
Nov 17, 2006
Approved
Time to decision
1,418 days
Received Dec 30, 2002. Calendar days, including time FDA spent waiting on the applicant.
Pathway
PMA
Device class
Class III
The decision
- FDA number
- P020056
- Device name
- NATRELLE SILICONE-FILLED BREAST IMPLANTS
- Applicant
- Allergan
- Applicant location
- Irvine, CA
- Received
- Dec 30, 2002
- Decided
- Nov 17, 2006
- Decision
- Approved
- Supplements
- 56 in FDA's data for this PMA. See them on the FDA record
Device type
- Device class
- Class III
- Regulation
- 21 CFR 878.3540
FDA's approval statement
As written in FDA's record.
APPROVAL FOR THE INAMED SILICONE-FILLED BREAST IMPLANTS. THIS DEVICE IS INDICATED FOR BREAST AUGMENTATION FOR WOMEN AT LEAST 22 YEARS OLD AND FOR BREAST RECONSTRUCTION FOR WOMEN OF ANY AGE. BREAST AUGMENTATION INCLUDES PRIMARY BREAST AUGMENTATION TO INCREASE THE BREAST SIZE, AS WELL AS REVISION SURGERY TO CORRECT OR IMPROVE THE RESULT OF A PRIMARY BREAST AUGMENTATION SURGERY. BREAST RECONSTRUCTION INCLUDES PRIMARY RECONSTRUCTION TO REPLACE BREAST TISSUE THAT HAS BEEN REMOVED DUE TO CANCER OR TRAUMA OR THAT HAS FAILED TO DEVELOP PROPERLY DUE TO A SEVERE BREAST ABNORMALITY. BREAST RECONSTRUCTION ALSO INCLUDES REVISION SURGERY TO CORRECT OR IMPROVE THE RESULT OF A PRIMARY BREAST RECONSTRUCTION SURGERY.
How new is this?
These are facts about FDA's records. They are not a judgment about the device.
- It is not the first decision under product code FTR. The earliest in FDA's data is P030053, decided Nov 17, 2006.
- It is not on FDA's public list of Breakthrough Devices with marketing authorization (list dated June 30, 2026). FDA does not publish which devices hold the designation before they are authorized, and the list is updated only a few times a year.
Source documents
Other decisions for Allergan
Matched on the applicant name as FDA recorded it. A company that files under several names will have more.
- SKINVIVE by JUVEDERM®PMA supplement
P110033-S099 · Decided Jun 11, 2026 · 394 days after receipt · Panel Track
Device type: Implant, dermal, for aesthetic use (LMH) · General & Plastic Surgery
K233732 · Decided Sep 12, 2024 · 296 days after receipt
Device type: Dermal Cooling Pack/Vacuum/Massager (OOK) · General & Plastic Surgery
- Juvéderm® Voluma® XCPMA supplement
P110033-S070 · Decided Oct 6, 2023 · 177 days after receipt · Panel Track
Device type: Implant, dermal, for aesthetic use (LMH) · General & Plastic Surgery
5 more FDA decisions with a free account
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.